Synonyms: compound 7 [PMID: 28368581] | CORT-125134 | CORT125134
Compound class:
Synthetic organic
Comment: Relacorilant (CORT125134; Corcept Therapeutics) is an orally bioavailable selective glucocorticoid receptor (GR) modulator (antagonist) [4]. It was originally developed as a treatment for Cushing syndrome, and was subsequently identified as offering antineoplastic potential.
![]() Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
Bioactivity Comments |
Relacorilant reverses the immunosuppressive effects of cortisol [3]. Inhibits several CYP enzymes, including CYP3A4 (IC50 1.3 μM) and CYP2C8 (IC50 0.21 μM). No no induction of CYP1A2, CYP2B6, or CYP3A4 was observed. |
Selectivity at nuclear hormone receptors | ||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | |||||||||||||||||||||||||||||||||
|